Dr. Michel Shami, MD

Claim this profile

Texas Retina Associates

Studies Retinal Disease
Studies Diabetic Retinopathy
6 reported clinical trials
8 drugs studied

Affiliated Hospitals

Image of trial facility.
Texas Retina Associates

Clinical Trials Michel Shami, MD is currently running

More about Michel Shami, MD

Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Michel Shami, MD has experience with
  • Placebo
  • Faricimab
  • Fenofibrate
  • Bevacizumab
  • Immediate Vitrectomy
  • Deferred Vitrectomy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michel Shami, MD specialize in?
Michel Shami, MD focuses on Retinal Disease and Diabetic Retinopathy. In particular, much of their work with Retinal Disease has involved treating patients, or patients who are undergoing treatment.
Is Michel Shami, MD currently recruiting for clinical trials?
Yes, Michel Shami, MD is currently recruiting for 6 clinical trials in Lubbock Texas. If you're interested in participating, you should apply.
Are there any treatments that Michel Shami, MD has studied deeply?
Yes, Michel Shami, MD has studied treatments such as Placebo, Faricimab, Fenofibrate.
What is the best way to schedule an appointment with Michel Shami, MD?
Apply for one of the trials that Michel Shami, MD is conducting.
What is the office address of Michel Shami, MD?
The office of Michel Shami, MD is located at: Texas Retina Associates, Lubbock, Texas 79424 United States. This is the address for their practice at the Texas Retina Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.